NMN (nicotinamide mononucleotide) is a precursor to NAD+, a coenzyme essential for cellular energy production, DNA repair, and mitochondrial function. If you're considering NMN supplementation, the most pressing question is how much to take. Current evidence from human trials suggests that effective doses range from 250 mg to 1000 mg daily, with the majority of published research centered on 500–1000 mg. However, optimal dosing depends on your age, baseline NAD+ status, health goals, and individual tolerance. This guide walks you through the evidence-based dosing framework, practical considerations, and what the research actually shows.

How NMN Works and Why Dosage Matters

NMN is converted to NAD+ in your cells through enzymatic pathways involving the enzyme NMN adenylyltransferase (NMNAT). NAD+ levels naturally decline with age—roughly 50% lower by age 60 compared to youth—and this decline is linked to reduced energy metabolism, impaired DNA repair, and accelerated aging. By supplementing with NMN, you aim to replenish NAD+ pools and support cellular function. Dosage matters because you need sufficient NMN to achieve meaningful increases in tissue NAD+ levels, but excessive doses offer no additional benefit and may introduce unnecessary cost and potential side effects.

Evidence-Based Dosing Range in Human Studies

The human clinical trial data on NMN is still relatively limited compared to long-established supplements, but several rigorous studies have established a working dosage framework:

The preponderance of evidence points to 500–1000 mg daily as the current